ANRO earnings date and last-quarter result: next report 2026-08-12, last quarter beat, P/E -10.98. Updated 2026-07-23.
Alto Neuroscience (ANRO) Research Hub
Alto Neuroscience (ANRO) trades on NYSE, US in the Healthcare (Biotechnology) sector. As of 2026-10-26, shares last closed at 22.11 USD (+0.64%), in a range — insufficient history for 200-DMA. Valuation: trailing P/E -10.98, market cap 0.96B. This hub links to the full technical, earnings and options research available for ANRO.
Last updated 2026-10-26 · Source: end-of-day prices (adjusted); indicators computed by SniperIQ
| Sector | Healthcare (Biotechnology) |
|---|---|
| Exchange | NYSE, US |
| Last close | 22.11 USD (+0.64%) |
| 52-week range | 20.85 USD – 37.48 USD |
| Trend regime | Range |
| 14-day RSI | 42.3 (Bearish) |
| Trailing P/E | -10.98 |
| Market cap | 0.96B |
| Dividend yield | 0.00% |
| Next earnings | 2026-08-12 |
Available research for ANRO
Covered Call on ANRO: how it works, illustrative setup around the real 22.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Iron Condor on ANRO: how it works, illustrative setup around the real 22.11 USD price, max profit/loss, breakeven and when to use it. Educational.
Protective Put on ANRO: how it works, illustrative setup around the real 22.11 USD price, max profit/loss, breakeven and when to use it. Educational.
ANRO technical analysis: range, last 22.11 USD, RSI 42.3, 52w range 20.85 USD–37.48 USD, real support/resistance. Updated 2026-10-26.
More on SniperIQ
Frequently asked questions
What sector is ANRO in?
Alto Neuroscience (ANRO) is classified under Healthcare (Biotechnology), listed on NYSE, US.
Is ANRO in an uptrend or downtrend?
As of 2026-10-26, ANRO is in a range — insufficient history for 200-DMA. See the full technical research page for support and resistance levels.
What is ANRO's trailing P/E ratio?
ANRO's trailing P/E is -10.98, with a market cap of 0.96B. See the earnings research page for full valuation detail.
When does ANRO next report earnings?
ANRO is next scheduled to report earnings on 2026-08-12.